Gilead Sciences
GILD
NASDAQ
IPO1992
about GILD
Gilead Sciences develops innovative pharmaceuticals to treat conditions such as HIV/AIDS, hepatitis C, and other serious diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $115.54 | $115.85 | $114.63 | $143.78B | 1.88M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$1.57 | 23.56 | 20.42 | 34.93% | 27.68% | 2.74% |